RXRX icon

Recursion Pharmaceuticals
RXRX

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$8
18% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Needham
Needham
Gil Blum
63% 1-yr RXRX win rate
11 Sep ‘25 1 month ago